WAYNE, N.J., May 12, 2011 /PRNewswire/ -- Jeremy Cannon, M.D., trauma surgeon at Brooke ArmyMedical Center in San Antonio, Texas, has issued a modified statement surrounding MAQUET Cardiovascular's recent announcement on April 28, 2011, that the U.S. Food and Drug Administration
"The ability to bring environmental control and life support equipment on every run for inter-hospital transport could truly enable centralized care of the most critically ill respiratory failure patients and others as ECLS applications are explored further," said Dr. Cannon.*
The CARDIOHELP System is the world's smallest portable heart-lung support system providing extracorporeal life support (ECLS) to replace or support a patient's circulation and respiration. The product is expected to be commercially available in the United States later this year.
*The opinions expressed by Dr. Cannon are solely his own and do not represent an endorsement by or the views of the United States Air Force, the Department of Defense, or the United States Government.
SOURCE MAQUET Cardiovascular
Subscribe to our Free Newsletters!
Immunotherapy is a type of treatment method that works by using certain components of a person's ...
Increasing weight and obesity are some of the most common health problems today. A smart weight ...View All